IgG and IgM autoantiidiotype antibodies against antibody to HBsAg in chronic hepatitis B

Authors

  • Miren Zuriñe Ibarra,

    1. Department of Gastroenterology, Fundación Jiménez Diáz, Universidad Autónoma, 28040 Madrid, Spain
    Search for more papers by this author
  • Ignacio Mora,

    1. Department of Gastroenterology, Fundación Jiménez Diáz, Universidad Autónoma, 28040 Madrid, Spain
    Search for more papers by this author
  • Dr. Juan Antonio Quiroga,

    1. Department of Gastroenterology, Fundación Jiménez Diáz, Universidad Autónoma, 28040 Madrid, Spain
    Search for more papers by this author
    • Dr. Quiroga is a Research Fellow of the Fundación Conchita Rábago, Spain.

  • Dr. Javier Bartolomé,

    1. Department of Gastroenterology, Fundación Jiménez Diáz, Universidad Autónoma, 28040 Madrid, Spain
    Search for more papers by this author
    • Dr. Bartolomé is a Research Fellow of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS), Spain.

  • Faustino La Banda,

    1. Department of Gastroenterology, Fundación Jiménez Diáz, Universidad Autónoma, 28040 Madrid, Spain
    Search for more papers by this author
  • Juan Carlos Porres,

    1. Department of Gastroenterology, Fundación Jiménez Diáz, Universidad Autónoma, 28040 Madrid, Spain
    Search for more papers by this author
  • Vicente Carreño M.D.

    Corresponding author
    1. Department of Gastroenterology, Fundación Jiménez Diáz, Universidad Autónoma, 28040 Madrid, Spain
    • Department of Gastroenterology, Fundación Jiménez Diáz, Avenida Reyes Católicos, 2, 20840 Madrid, Spain
    Search for more papers by this author

Abstract

Antibody directed against HBsAg carries idiotypic determinants that may induce an autoantiidiotype antibody response. We describe a solid-phase radioimmunoassay which allows specific detection of either IgG or IgM antibody to antibody directed against HBsAg. Among 138 chronic hepatitis B virus carriers, IgG autoantiidiotype was detected in 98 (71%) and IgM autoantiidiotype in 110 (80%). The autoantiidiotype reaction was blocked with antibody directed against HBsAg after removal of immune complexes by polyethylene glycol precipitation. The prevalence and levels of both classes of autoantiidiotype antibodies were highest in patients with hepatitis B virus DNA or HBeAg in serum. During follow-up, patients who lost hepatitis B virus DNA and HBeAg from serum had lower titers of autoantiidiotype and were less likely to have autoantiidiotype than patients who persisted in having hepatitis B virus DNA and HBeAg in serum. Thus, the presence and titer of autoantiidiotype correlated with serologic evidence of active viral replication in chronic hepatitis B. These findings suggest that the antibody directed against HBsAg response may play a role in modulating viral replication in chronic hepatitis B.

Ancillary